Tamada Y - Search Results

1

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

Suzuki N, Aoki D, Tamada Y, Susumu N, Orikawa K, Tsukazaki K, Sakayori M, Suzuki A, Fukuchi T, Mukai M, Kojima-Aikawa K, Ishida I, Nozawa S. Suzuki N, et al. Among authors: tamada y. Gynecol Oncol. 2004 Nov;95(2):290-8. doi: 10.1016/j.ygyno.2004.06.024. Gynecol Oncol. 2004. PMID: 15491748

2

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.

Aoki D, Suzuki N, Susumu N, Noda T, Suzuki A, Tamada Y, Higashiguchi A, Oie S, Nozawa S. Aoki D, et al. Among authors: tamada y. Hum Cell. 2005 Sep;18(3):143-6. doi: 10.1111/j.1749-0774.2005.tb00004.x. Hum Cell. 2005. PMID: 17022146

3

Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.

Nomura H, Tamada Y, Miyagi T, Suzuki A, Taira M, Suzuki N, Susumu N, Irimura T, Aoki D. Nomura H, et al. Among authors: tamada y. Oncol Res. 2006;16(6):289-97. doi: 10.3727/000000006783981035. Oncol Res. 2006. PMID: 17476974

4

Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.

Tamada Y, Iida S, Aoki D, Nozawa S, Irimura T. Tamada Y, et al. Oncol Res. 1999;11(5):233-41. Oncol Res. 1999. PMID: 10608618

5

8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin.

Suzuki N, Aoki D, Orikawa K, Suzuki A, Susumu N, Tamada Y, Sakayori M, Tsukazaki K, Mukai M, Kikuchi H, Ishida I, Nozawa S. Suzuki N, et al. Among authors: tamada y. Placenta. 2006 Feb-Mar;27(2-3):333-9. doi: 10.1016/j.placenta.2005.02.005. Placenta. 2006. PMID: 16338478

6

Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.

Suzuki N, Tamada Y, Shigirahara K, Suzuki A, Susumu N, Ishida I, Aoki D. Suzuki N, et al. Among authors: tamada y. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):996-1006. doi: 10.1111/j.1525-1438.2007.01147.x. Epub 2007 Nov 20. Int J Gynecol Cancer. 2008. PMID: 18028379

7

[Conservative hormonal therapy for endometrial cancer].

Susumu N, Aoki D, Tamada Y, Banno K, Suzuki A, Suzuki N, Nozawa S. Susumu N, et al. Among authors: tamada y. Nihon Rinsho. 2004 Oct;62 Suppl 10:375-80. Nihon Rinsho. 2004. PMID: 15535271 Review. Japanese. No abstract available.

8

Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary.

Tamada Y, Takeuchi H, Suzuki N, Susumu N, Aoki D, Irimura T. Tamada Y, et al. Cancer Sci. 2007 Oct;98(10):1586-91. doi: 10.1111/j.1349-7006.2007.00582.x. Epub 2007 Aug 16. Cancer Sci. 2007. PMID: 17711507 Free PMC article.

9

Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells.

Tamada Y, Takeuchi H, Suzuki N, Aoki D, Irimura T. Tamada Y, et al. Tumour Biol. 2012 Aug;33(4):1215-22. doi: 10.1007/s13277-012-0369-4. Epub 2012 Mar 6. Tumour Biol. 2012. PMID: 22392500

10

A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells.

Tamada Y, Nomura H, Aoki D, Irimura T. Tamada Y, et al. Molecules. 2021 Oct 1;26(19):5962. doi: 10.3390/molecules26195962. Molecules. 2021. PMID: 34641504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters